To investigate the molecular mechanism(s) of insulin action on the expression of the angiotensinogen (ANG) gene in kidney proximal tubular cells, we constructed a fusion gene, pOGH (hANG N-1064/+27), containing the 5'-flanking regulatory sequence of the human ANG gene fused with the human growth hormone (hGH) gene as a reporter and stably integrated the fusion gene into the opossum kidney (OK) cell genomes. The level of expression of pOGH (hANG N-1064/+27) was quantified by the amount of immunoreactive hGH secreted into the medium. The addition of a high level of D(+)-glucose (25 mM) or phorbol 12-myristate 13-acetate (PMA, 10 -7 M) stimulated the expression of the fusion gene in OK cells. The stimulatory effect of glucose (25 mM) was blocked by insulin and tolrestat (an inhibitor of aldose reductase). Tolrestat also inhibited the increase of cellular DAG and PKC activity stimulated by 25 mM glucose. While insulin did not affect the cellular DAG and PKC activity, it did block the stimulatory effect of high glucose (25 mM) and PMA on the expression of the fusion gene. Finally, PD98059 (an inhibitor of mitogen-activated protein kinase kinase (MEK)) enhanced the stimulatory effect of high levels of glucose and blocked the inhibitory effect of insulin on the expression of the fusion gene as well as on the phosphorylation of MEK and mitogen-activated protein kinase (MAPK). In contrast, Wortmannin (an inhibitor of phosphatidylinositol-3-kinase) did not block the inhibitory effect of insulin on the ANG gene expression. These studies demonstrate that the action of insulin, blocking the stimulatory effect of a high level of D(+)-glucose (25 mM) on the ANG gene expression is mediated, at least in part, via the 5'flanking region of the ANG gene and MAPK signal transduction pathway.
Introduction
While hyperglycaemia has been implicated in the etiology of diabetic nephropathy, 1 the molecular mechanisms for the development of nephropathy in diabetes are not completely understood. In vivo studies have shown that angiotensin-converting enzyme (ACE) inhibitors and angiotensin-II receptor antagonists decrease proteinuria and slow the progression of nephropathy in diabetic patients, indicating that angiotensin II (Ang II) plays an important role in the development of nephropathy. [2] [3] [4] [5] [6] Studies have shown that the mRNA components of the renin-angiotensin-aldosterone system (RAAS), including angiotensinogen (ANG), renin, ACE and Ang-II receptors (AT 1 -receptors), are expressed in murine immortalised proximal tubular cell lines. [7] [8] [9] We have also reported that ANG mRNA and ANG protein are expressed in opossum and rat kidney proximal tubular cells. [10] [11] These studies indicate that intrarenal Ang II is probably derived from the ANG that is synthesised within the renal proximal tubular cells.
We have previously demonstrated that high levels of glucose stimulate that expression of the ANG gene in OK cells. 12 The addition of staurosporine or H-7 (an inhibitor of protein kinase C) and U73122 (an inhibitor of phospholipase C and A 2 ) blocked the stimulatory effect of glucose, indicating that the PKC signal transduction pathway plays a regulatory role on the expression of the ANG gene in OK cells. More recently, studies by Aubert et al. 13 have shown that insulin down-regulates ANG mRNA expression and ANG secretion in cultured adipose cells, suggesting that insulin may directly regulate the expression of the ANG gene. The molecular mechanism(s) of insulin action on the expression of the ANG gene, however, is not defined.
In this paper, we report that the expression of the fusion gene, pOGH (ANG N-1064/+27) containing the 5'-regulatory sequence of the human ANG gene fused with the human growth hormone (hGH) gene as a reporter in OK cells was stimulated by a high concentration of glucose (25 mM) and by PMA (phorbol 12-myristate 13-acetate, an activator of PKC). The stimulatory effect of glucose was blocked by insulin and tolrestat (an inhibitor of aldose reductase 14 ) . Tolrestat also blocked the increase of cellular diacylglycerol (DAG) levels and PKC activity stimulated by the high level of glucose (25 mM), while insulin had no effect on these parameters. The stimulatory effect of PMA was blocked by insulin. The addition of PD98059 (an inhibitor of MAP kinase kinase [MEK] 15 ), blocked the inhibitory effect of insulin on the expression of the fusion gene as well as on the phosphorylation of MEK and MAPK stimulated by insulin. The addition of Wortmannin (an inhibitor of phosphatidylinositol(PI)-3 kinase 16 ) did not block the inhibitory effect of insulin on the expression of the fusion gene.
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Radioimmunoassay for human growth hormone (hGH)
The radioimmunoassay kit for hGH (RIA-hGH) was a gift from NIADDK, NIH, USA. The assay procedure has been described previously. 18 NIAMDD-hGH-I-1 (AFP-4793 B) was used for both iodination and as a hormone standard. The limit of sensitivity of the assay was 0.1 ng/ml. The inter-and intraassay coefficients of variation were 12% (n=10) and 10% (n=10), respectively.
Assays for cellular DAG and PKC activity
Cellular levels of DAG and PKC activity were quantified with kits (RPN 200 and RPN 77) purchased from Amersham Life Science (Oakville, Ontario, Canada) in accordance with the manufacturer's instructions.
Prior to the PKC activity measurement, the OK W1 cells were separated into cytosolic and membrane fractions. Briefly, the cells were harvested in 3 ml of 20 mM Tris HCl, pH 7.5, containing 2 mM EDTA, 0.5 mM EGTA, 1 mM phenyl methyl sulfonyl fluoride (PMSF), 1 mM DTT, 25 µg/ml Leupeptin, 1 µg/ml Pepstatin A and 330 mM sucrose and kept on ice. Cells were then homogenised with a Dounce-bound glass homogeniser (Type B) and centrifuged at 100,000 x g for 30 minutes at 4°C. The supernatants (cytosolic fraction) were recovered and stored on ice until assayed. The pellets were resuspended in 3 ml of 20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 0.5 mM EGTA, 1 mM PMSF, 1 mM DTT, 25 µg/ml Leupeptin, 1 µg/ml Pepstatin A and 0.2% Triton X-100 and incubated on ice for 30 minutes. Following centrifugation at 100,000 x g for 30 minutes, the supernatant fractions were collected as the membrane fraction and stored on ice until assayed. The effects of treatments on PKC activity in OK W1 cells were expressed as changes in the ratio of PKC enzymatic activity in the cytosolic and membrane fractions. 19 Cloning of the human angiotensinogen (hANG) gene promoter The 5'-flanking region of the hANG gene was cloned by the polymerase chain reaction (PCR) from a human liver genomic library (Clontech, La Jolla, CA, USA). The forward primer: 5' GTC AGT GAA TGT ACA GCT TCT GCC 3' and the reversed primer: 5' TAG TAC CCA GAA CAA CGG CAG CTT 3' corresponding to the nucleotide sequences of N-1064 to N-1041 and N-2 to N+27 of the hANG gene 20 were used in PCR, respectively.
The DNA fragment hANG N-1064 to N+27 obtained by PCR was initially cloned in the plasmid, pCRII-1 (In Vitrogen, La Jolla, CA) and subsequently subcloned in the modified expression vector, pOGH. 17 The sequence and orientation of the fusion genes were confirmed by dideoxy sequencing with SP6 primer (Promega-Fisher, Inc) and restriction enzyme digestion mapping.
Cell culture
The OK proximal tubular cell line was obtained from the American Tissue Culture Collection (ATCC) (Rockville, MD, USA). This cell line is derived from the kidney of a female American opossum and retains several properties of proximal tubular epithelial cells in culture. 21, 22 We had previously reported that the OK cells express a low level of ANG mRNA. 10 The culture conditions of the OK cells have been described previously. 12, 17, [23] [24] OK cell stable transformants OK W1 cells are stable transformants with the pOGH (hANG N-1064+27) fusion gene integrated into the OK cellular genome. The method for the selection of OK cell stable transformants with the high expression of the fusion gene was similar to the method described previously for OK 27 cells and OK 13 cells with pOGH (rANG N-1498/+18) and pTKGH stably integrated into the cellular genomes, respectively. 17
Effect of D(+)-glucose and insulin on the secretion of the immunoreactive ANG protein
OK W1 cells were plated at a density of 1-2 X 10 5 cells/well in 6-well plates and incubated overnight in DMEM containing 5 mM D(+)-glucose and 10% FBS. To arrest growth, cells were incubated in a serum-free and low glucose concentration (5 mM) medium for 24 hours. Subsequently, cells were incubated for 24 hours in medium containing 5 mM glucose, 25 mM glucose or 25 mM glucose with 10 -7 M insulin and 1% depleted fetal bovine serum (dFBS). The media were concentrated by Centricon-30 (Amicon Inc, Beverly, MA, USA) to less than 5% of the original volume before Western blotting. The depleted fetal bovine serum (i.e. depleted of endogenous steroid and thyroid hormones) was prepared by incubation with 1% activated charcoal and 1% AG 1 X 8 ion-exchange resin (Bio-Rad Laboratories, Richmond, CA, USA) for 16 to 24 hours at room temperature as described by Samuel et al. 25 Media tonicity or osmolality was adjusted for the changes in glucose concentration by the addition of D-mannitol.
Effect of glucose, insulin and tolrestat on the expression of the fusion gene
To determine the specificity of the effect of D(+)glucose on the expression of the ANG-GH fusion gene in OK W1 cells, 5 or 25 mM of L-glucose, Dmannitol or 2-deoxy-D-glucose were added to the culture medium of growth-arrested cells and the cells were incubated for 24 hours. The media were then collected and stored at -20°C until assayed for IR-hGH.
To study the inhibitory effect of insulin and tolrestat on the expression of the fusion gene in OK W1 cells, OK W1 cells were incubated for 24 hours in media with 25 mM glucose and insulin concentrations ranging between 10 -11 to 10 -5 M or tolrestat (10 -7 M to 10 -4 M). At the end of the incubation period, media were collected and stored at -20°C until assayed for IR-hGH.
Antagonistic effects of insulin and PMA on the expression of the fusion gene
To investigate the antagonistic effect of insulin and PMA on the expression of the fusion gene in OK W1 cells, PMA at concentrations ranging between 10 -11 to 10 -5 M was added along with insulin (10 -7 M) to media containing 25 mM glucose and the cells were incubated for 24 hours. These experiments were repeated using a fixed concentration of PMA (10 -7 M) and concentrations of insulin ranging between 10 -11 to 10 -5 M. At the end of the incubation period, media were collected and stored at -20°C until assayed for IR-hGH.
Effect of PD98059 and Wortmannin on the expression of the fusion gene
To investigate whether MAP kinase or phosphoinositol-3 kinase pathways might be involved in mediating the effect of high levels of glucose on the expression of the fusion gene in OK W1 cells, cells were incubated for 24 hours with 5 mM glucose, 25 mM glucose, 25 mM glucose in the presence or absence of PD98059 (10 -7 to 10 -4 M) or Wortmannin (10 -8 M to 10 -5 M). Similarly, to study the signal transduction pathway of insulin involved in the expression of the fusion gene in OK W1 cells, confluent cultures were incubated for 24 hours in media with 25 mM glucose, 10 -7 M insulin and concentrations of PD98059 ranging between 10 -7 to 10 -4 M, or Wortmannin ranging from 10 -9 to 10 -5 M. At the end of the incubation period, media and cells were collected and stored at -20°C until assayed for IR-hGH.
Effect of insulin on the phosphorylation of mitogen-activated protein kinase kinase (MEK 1/2) and p44/42 MAPK in OK W1 cells
The effect of insulin on the activation of MAPK signal transduction pathway was determined by the phosphorylation of the MEK 1/2 and p44/42 MAPK by employing Phospo Plus MEK 1/2 and Phospo Plus p44/42 MAP kinase antibody kits, respectively. Briefly, cells were plated at 5 X 10 4 cells/well in 6-well plates in 5 mM glucose DMEM containing 10% FBS, and were synchronised in 5 mM glucose medium for 24 hours. Subsequently, the cells were incubated in 5 mM glucose, 25 mM glucose, 25 mM glucose and PD98059 (10 -5 M) for 15 minutes. Insulin (10 -7 M) was then added and the cells were incubated for another 10 minutes. Cells were lyzed in 100 µl lysis buffer (62.5 mM Tris-HCl, pH 6.8 containing 2% sodium dodecyl sulfate (SDS) (W/V), 10% glycerol, 50 mM DTT and 0.1% bromophenol blue (W/V)) and harvested in Eppendorf tubes. The cell lysates were sonicated for two seconds, heated at 95°C for five minutes and then centrifuged at 12000 x g for two minutes at 4°C. Small aliquots (20 µl) of the supernatants were subjected to polyacrylamide gel (10%) electrophoresis containing sodium dodecyl sulfate (SDS-PAGE) and then transferred onto a nitrocellulose membrane (Hybond-P, Amersham-Pharmacia Biotech, Inc. Baie d'Urfe, Quebec, Canada). The membrane was then blotted for the phosphorylated MEK 1/2 or p44/42 MAPK by employing the Phospho Plus MEK 1/2 antibody kit or Phospho Plus p44/42 MAP kinase antibody kit, respectively. Immunoreactive proteins were visualised with ECL-enhanced chemiluminescence detection system (Amersham-Pharmacia Biotech, Inc.) followed by exposure to Kodak X-ray film.
Statistical analysis
The treatment groups were assayed in triplicate (n=3) and the experiments were repeated at least three times. The data were analysed with Student's t test or an analysis of variance (Anova). A probability level of p<0.05 was regarded as statistically significant.
Results
Effect of D(+)-glucose, insulin and tolrestat on the expression of human ANG gene promoter activity
The expression of the fusion gene, pOGH (hANG N-1064/+18) in OK W1 cells was increased by 150% (p<0.001) with 25 mM D(+)-glucose medium compared with cells incubated in 5 mM D(+)glucose medium (Figure 1 ). The addition of insulin to the culture media abolished the glucose (25 mM) stimulation of the ANG gene expression in a dose-dependent manner with a maximal effect at 10 -7 M to 10 -5 M (Figure 1 ). The effective dose of insulin, 10 -7 M, was routinely used in all subsequent experiments.
The glucose stimulation of the ANG gene expression was also inhibited by tolrestat in a dose-dependent manner with a maximal effect at 10 -4 M (Figure 2 ). This inhibitor, even at the high-est concentrations tested, had no effect on cell viability as assessed by Trypan blue dye exclusion (data not shown).
Cellular levels of DAG and PKC activity in OK W1 cells
Culture of OK W1 cells in 25 mM glucose increased DAG levels ( Figure 3A ) and PKC activity ( Figure 3B ) by 2-and 1.75-fold, respectively. Tolrestat (10 -4 M) prevented these increases, while insulin (10 -5 M) had no inhibitory effect.
Antagonistic effect of insulin and PMA on the expression of the fusion gene
In experiments where the concentration of insulin was held constant at 10 -7 M and increasing concentrations of PMA were tested, the inhibitory effect of insulin on the ANG gene expression was blocked ( Figure 4A ). Conversely, the stimulation of the ANG gene expression in OK W1 cells by 25 mM glucose and 10 -7 M PMA was reversed by insulin treatment ( Figure 4B ). The loss of this stimulatory effect was proportional to the concentration of insulin. At the highest concentration of insulin tested, 10 -5 M,ANG gene expression in OK W1 cells was about 1.2-fold greater than that of cells incubated in media with 5 mM glucose (not statistically significant, p>0.05) ( Figure 4B ). Figure 5 shows that, whilst overnight incubation of OK W1 cells in 25 mM glucose with a high concentration of PMA (10 -5 M) did not block the inhibitory effect of insulin on the expression of the ANG gene, the stimulatory effect of PMA (10 -7 M) was completely abolished.
Effect of PD98059 or Wortmannin on the expression of the fusion gene
The addition of PD98059 alone at 10 -5 to 10 -4 M significantly enhanced the expression of the ANG gene in OK W1 cells when incubated in 25 mM glucose medium ( Figure 6A ), whereas Wortmannin (10 -8 to 10 -5 M) had no effect ( Figure 6B ). Furthermore, the inhibitory effect of insulin on the expression of the ANG gene in OK W1 cells was blocked by PD98059 in a dose-dependent manner ( Figure 7A ) but was unaffected by Wortmannin at concentrations ranging between 10 -8 to 10 -4 M ( Figure 7B ). These studies demonstrate that the effect of insulin on attenuation of the stimulatory effect of high concentration glucose on the expression of the fusion gene in OK W1 cells is mediated, at least in part, via activation of MEK activity, but not via phosphatidylinositol-3 kinase activity. Figures 8 and 9 show that insulin (10 -7 M) stimulated the phosphorylation of MEK 1/2 and MAPK (p44/42), respectively. PD98059 (10 -5 M) inhibited the phosphorylation of MEK 1/2 and p44/42 MAPK stimulated by insulin. These studies demonstrate that the MEK and MAPK signal transduction pathways are present in OK cells. Figure 10 shows that the addition of D(+)-glucose (25 mM) in the absence or presence of insulin (10 -7 ), tolrestat (10 -4 ), staurosporine (10 -9 M), H-7 (10 -7 ) or PMA (10 -7 ) had no effect on the expression of pTKGH in OK 13 cells compared with the control (i.e. 5 mM glucose). OK 13 cells are stable transformants with the plasmid TKGH stably integrated into the cellular genomes as described previously. 17 Figure 4 (A) Effect of PMA on the expression of the fusion gene in OK W1 cells incubated with 25 mM glucose and insulin (10 -7 M). Cells were incubated for 24 hours in the media with 5 mM or 25 mM glucose or 25 mM glucose plus 10 -7 M insulin in the absence or presence of various concentrations of PMA (i.e. 10 -11 to 10 -5 M). Media were harvested and assayed for the level of IR-hGH. Results are expressed as (mean ± S.D., N=3) as a percentage of the levels found in media from cells incubated with 5 mM glucose (i.e. 0.36 ± 0.01 ng/ml/106 cells) (**p<0.01 and ***p<0.005). Similar results were obtained from two other experiments. (B) Effect of insulin on the expression of the fusion gene in OK W1 cells incubated with 25 mM glucose and 10 -7 M PMA. Cells were incubated for 24 hours in the presence of 5 mM or 25 mM glucose plus 10 -7 M PMA in the absence or presence of various concentrations (i.e. 10 -11 to 10 -5 M) of insulin. Media were harvested and assayed for the level of IR-hGH. Results are expressed (mean ± S.D., N=3) as a percentage of the levels detected in the media from cells incubated with 5 mM glucose (i.e. 0.29 ± 0.01 ng/ml/10 6 cells) (*p<0.05 and ***p<0.005).
Effect of insulin on the phosphorylation of mitogen-activated protein kinase kinase (MEK 1/2) and MAPK (p44/42) in OK cells
Effect of D(+)-glucose, insulin, tolrestat, staurosporin, H-7 and PMA on the expression of PTKGH in OK 13 cells
Figure 5
Effect of a 24-hour pre-incubation with PMA (10 -5 M) on the expression of the fusion gene in OK W1 cells incubated with 25 mM glucose with or without insulin (10 -7 M). Cells pre-incubated for 24 hours in the presence of 25 mM glucose and10 -5 M PMA were transferred into fresh medium containing insulin (10 -11 to 10 -5 M) or 10 -7 M PMA and incubated for an additional 24 hours. The media were then harvested and assayed for IR-hGH. Results are expressed (mean ± S.D., N=3) as a percentage of the levels detected in media from cells incubated with 25 mM glucose (i.e. 0.72 ± 0.05 ng/ml/10 6 cells) (*p<0.05, **p<0.01 and ***p<0.005). Similar results were obtained from two other experiments. 
Discussion
The present results indicate a novel action of insulin in inhibition of the expression of the human ANG gene via the 5'-flanking regulatory region of the ANG gene. This inhibitory action appears to be independent of the PKC signal transduction pathway and may be mediated, at least in part, by the activation of the MAPK signal transduction pathway.
Our data shows that high levels of glucose (25 mM) stimulate the expression of the human ANG-GH fusion gene (Figure 1 ). Similar observations have also been obtained from four other independent clones with the human ANG-GH fusion gene integrated into their genomes. These studies indicate that the site(s) of genomic integration have not yet affected the expression of the fusion gene. Incubation with 25 mM D-mannitol, L-glucose and 2-deoxy-D-glucose did not stimulate the expression of the fusion gene in OK W1 cells (data not shown), indicating that the effect of glucose is probably mediated via the metabolic products of D(+)-glucose. Insulin has been reported to attenuate the expression of ANG mRNA in rat hepatoma cells 26 and to downregulate the expression and secretion of ANG in cultured adipose cells. 13 More recently, we have reported that insulin inhibited the secretion of the ANG protein and the expression of ANG mRNA in rat immortalised renal proximal tubular cells (IRPTC). 27 Our results, together with those of Chang and Perlman 26 and Aubert et al., 13 suggest that insulin may regulate ANG secretion and gene expression. The molecular mechanism(s) of insulin action may be mediated, at least in part, via the 5'-flanking regulatory sequence of the ANG gene.
Tolrestat blocked the stimulatory effect of 25 mM glucose on the expression of the ANG gene in a dose-dependent manner (Figure 2) . These observations suggest that the stimulatory effect of high levels of glucose is mediated, at least in part, via the polyol pathway as previously suggested by Tilton et al. 28 The mechanisms linking polyol pathway activity to increase hANG promoter activity are not yet clear but may be related to increased synthesis of diacylglycerol (DAG) and subsequent stimulation of PKC activity, as recently described in mesangial cells by Keogh et al. 29 and in proximal tubules by Bleyer et al. 30 and Zhang et al. 31 Our findings, showing that tolrestat prevents the increase in DAG levels and PKC activity in OK W1 cells incubated in 25 mM glucose ( Figure 3A and  3B) , lend further support to this hypothesis. Interestingly, insulin did not block the increases in Media were harvested and assayed for the level of IR-hGH. Results are expressed (mean ± S.D., N=3) as a percentage of the levels detected in media from cells incubated with 5 mM glucose (i.e 0.44 ± 0.01 ng/ml/10 6 cells) (*p<0.05 and ***p<0.005). Similar results were obtained from two other experiments. Figures 3A and 3B) .
While we do not completely understand the opposing effects of PMA and insulin on the activity of the hANG gene promoter ( Figures 4A and  4B) , our observations raise the possibility that the antagonistic effect of these two agents may be mediated via the PKC signal transduction pathway. Surprisingly, overnight incubation of OK W1 cells with 10 -5 M PMA did not affect the inhibitory effect of insulin on the expression of the fusion gene but did abolish the stimulatory effect of PMA (10 -7 M) ( Figure 5 ). These studies indicate that the inhibitory effect of insulin on the expression of the ANG gene may be independent of PKC activity and may be mediated downstream of the PKC signal transduction pathway or other signal transduction pathways.
We were equally surprised that PD98059 at 10 -5 to 10 -4 M enhanced the stimulatory effect of 25 mM glucose ( Figure 6A ) on the expression of the fusion gene in OK W1 cells, whereas Wortmannin (10 -8 to 10 -5 M) was without effect ( Figure 6B) . These studies raise the possibility that the signaling through the MAPK pathway may suppress the expression of the fusion gene. Indeed, our results show that PD98059 blocked the inhibitory effect of insulin in a dose-dependent manner ( Figure  7A ), whereas Wortmannin had no effect ( Figure   7B ). To demonstrate that the MAPK signal transduction pathway is present in OK cells, we determined the effect of insulin on the phosphorylation of MEK 1/2 and MAPK (p44/42) in OK cells. Our studies showed that insulin stimulated the phosphorylation of MEK 1/2 ( Figure 8 ) and MAPK (p44/42) ( Figure 9 ), an effect that can be blocked by PD98059. It should be pointed out that our data did not provide conclusive evidence that the activation of MEK/MAPK pathway leads to a decrease of ANG-GH gene expression. Studies are underway, however, in our laboratory to transfect the plasmid containing the MEK/MAPK cDNA into OK W1 cells in order to elucidate the relationship of MAPK activation and ANG-GH gene expression. At present, the exact molecular mechanism(s) of insulin action (i.e. events downstream of the activation of MEK and MAPK) on the expression of the ANG gene is not known and further studies are underway in our laboratory to establish these mechanism(s).
OK 13 is a cell line that has been stably transfected with a fusion gene: pTKGH, containing the promoter/enhancer DNA sequence of the viral thymidine kinase gene fused with human growth hormone as a reporter. 17 These cells were used as control cells to examine the effect of glucose, insulin, tolrestat, staurosporine, H-7 and PMA on the expression of pTKGH. In contrast to the Figure 8 Effect of insulin on the phosphorylation of MEK 1/2 in OK cells. After 24 hours incubation period in 5 mM glucose medium, OK W1 cells were incubated in 5 mM glucose, 25 mM glucose, 25 mM glucose and insulin (10 -7 M) in the absence or presence of PD98059 (10 -5 M) for 15 minutes. Cells were then harvested and assayed for the phosphorylation of MEK 1/2 by the Phospho Plus MEK 1/2 antibody kit. The relative densities of the phosphorylated MEK 1/2 in the cells incubated in 5 mM glucose medium were considered as 100% control. Each point represents the mean ± SD of three dishes (*p<0.05). Similar results were obtained in another experiment.
Figure 9
Effect of insulin on the phosphorylation of MAPK 1/2 in OK cells. After 24 hours incubation period in 5 mM glucose medium, OK W1 cells were incubated in 5 mM glucose, 25 mM glucose, 25 mM glucose and insulin (10 -7 M) in the absence or presence of PD98059 (10 -5 M) for 15 minutes. Cells were then harvested and assayed for the phosphorylation of MAPK 1/2 by the Phospho Plus MAPK 1/2 antibody kit. The relative densities of the phosphoralated MAPK 1/2 in the cells incubated in 5 mM glucose medium were considered as 100% control. Each point represents the mean ± SD of three dishes (**p<0.05). Similar results were obtained in another experiment. effects of these agents on the promoter activity of the hANG gene, we did not observe any significant stimulation of expression of pTKGH by 25 mM glucose or PMA nor inhibition by insulin, tolrestat, staurosporine or H-7 ( Figure 10 ). These data demonstrate that the promoter/enhancer DNA sequence of the TK gene or the hGH reporter gene is not responsive to the addition of insulin or various drugs, and that the effect of a high glucose level and insulin on the expression of the human ANG gene promoter activity in OK W1 cells is gene specific. Finally, recent studies of Kang et al. 32 demonstrated that PKC isoforms are differentially regulated in the kidney of diabetic rats. Our preliminary (unpublished) results also showed that high levels of glucose and PMA stimulated the expression of PKCα isoform in rat immortalised renal proximal tubular cells. These results raise the possibility that insulin may differentially inhibit the expression and translocation of PKC isoform in the kidney and subsequently attenuate the expression of the ANG gene in diabetic renal proximal tubular cells. Indeed, our laboratory is actively investigating this possibility.
In summary, our studies show that a novel action of insulin is the inhibition of the stimulatory effect of high levels of glucose on the expression of the human ANG gene promoter. The inhibitory effect of insulin is independent of PKC activity and may be mediated, at least in part, via the MAPK kinase signal transduction pathway. Our results raise the possibility that the glucose stimulation of the ANG gene expression in proximal tubules and the activation of renal RAS may play a role in the cascade of biochemical alterations precipitating the loss of renal function in diabetic nephropathy. Our observations also provide a biochemical basis for understanding the beneficial effects of insulin and inhibitors of aldose reductase in animal models of diabetic nephropathy. 
